Skip to main content

The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Kjerulf A, Hansen DS, Sandvang D, Hansen F, Frimodt-Möller N. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS 2008;116:118–24.

The main purpose of the study was to investigate the frequency of ESBL-producing E. coli and Klebsiella strains in the Greater Copenhagen area. Four collections of strains were investigated: A) 380 consecutive E. coli and Klebsiella isolates primarily from urine, B) 200 gentamicin-resistant E. coli and Klebsiella isolates primarily from urine, C) 210 consecutive E. coli isolates from blood cultures, and D) 68 cefuroxime-resistant E. coli and Klebsiella isolates primarily from urine. Only one strain per patient was included. Strains with a zone diameter for cefpodoxime ≤23 mm were tested by a phenotypic confirmatory test for ESBL production and all screening test-positive strains were examined with PCR and nucleotide sequencing in order to detect the following ESBL genes: ctx-m, shv, tem and oxa. Strains resistant to cefoxitin were further examined with cefotetan±boronic acid in order to detect AmpC. An ESBL gene was detected in 3/3 confirmatory test-positive isolates from collection A, in 14/17 from collection B, and in 41/48 from collection D. The distribution of isolates with the ESBL and/or AmpC enzymes was as follows: CTX-M (n=41), SHV (n=14), AmpC (n=9), CTX-M and AmpC (n=2), SHV and AmpC (n=1). In conclusion, the frequency of ESBL-producing E. coli and Klebsiella isolates was low in the Copenhagen area of Denmark (0.8 %). The most common ESBL genes found in our study were ctx-m and shv genes.

Keywords: CTX-M; ESBL-producing E. coli and Klebsiella strains; antibiotic resistance; prevalence

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2008.00777.x

Affiliations: The National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen

Publication date: February 1, 2008

mksg/apm/2008/00000116/00000002/art00005
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more